Encorafenib
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 521 publications
Precision Thyroid Oncology Using Genetic-Based Therapies: A Narrative Review.
Journal: Thyroid : official journal of the American Thyroid Association
Published: October 20, 2026
Three Cases of Encorafenib Treatment for Recurrent BRAF-Mutated Colorectal Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: September 11, 2026
Giant scalp melanoma in an immunosuppressed patient.
Journal: JAAD case reports
Published: August 16, 2026
Biomarker-Guided Treatment Selection in Metastatic Colorectal Cancer: A Critical Review of Established and Emerging Therapies.
Journal: Critical reviews in oncology/hematology
Published: July 28, 2026
Encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the BECARE (GEM-2002) trial.
Journal: Neuro-oncology advances
Published: July 17, 2026
Eruptive Melanocytic Nevi Associated With Encorafenib and Cetuximab Therapy in Two Patients With BRAF V600E-Mutated Colorectal Cancer.
Journal: The Journal of dermatology
Published: June 25, 2026
Colorectal neuroendocrine neoplasm organoids reveal the potential therapeutic value of targeting BRAF mutations.
Journal: Journal of the Endocrine Society
Published: June 17, 2026
A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 17, 2026
Report from the 27th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Calgary, Alberta, 26-27 September 2025: Advances in Colon and Rectal Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: June 01, 2026
Genetic evaluation of encorafenib-associated kinases RAF1 and MAPK8 in pancreatic cancer: Exploratory mediation by circulating immune traits.
Journal: Translational oncology
Published: May 09, 2026
Treatment Selection Beyond Second Line in Metastatic Colorectal Cancer: Practical Sequencing of Cytotoxic Salvage Therapy, Anti-angiogenic Agents, Rechallenge Strategies, and Biomarker-Guided Treatments.
Journal: Journal of gastrointestinal cancer
Published: May 06, 2026
Last Updated: 11/08/2026